Preclinical development of a chemopreventive agent, 4-methylumbelliferone(4-MU) HHSN2512015000361 torfp: 2018-E07 PP: 9/17/18 to 9/16/19
Ended Awarded Last action
- Contract number
- 75N91018F00010
- Awardee
-
University Of Alabama At Birmingham UEI YND4PLMC9AN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,271,041
Award facts
- Opportunity
-
- N01CN201500036 Solicitation number
- Contract value 100% obligated
- $1,271,040.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Birmingham, AL 35294, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$5,417 | |
| Supplemental Agreement for work within scope | -$1,605 | |
| Supplemental Agreement for work within scope | -$11,324 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$100,636 | |
| Supplemental Agreement for work within scope | $857,168 | |
| Original award | $532,854 |
About this award
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to the University of Alabama at Birmingham (UAB) on September 17, 2018. The order, valued at $1,271,040.50, is for the preclinical development of the chemopreventive agent 4-methylumbelliferone (4-MU) under the agency's Preclinical Prevent Cancer Program. The work is being performed in Birmingham, Alabama and has a completion date of April 14, 2023. The order was not set aside for any specific business type.
UAB has issued two subcontracts under this order, one to the University of California, San Francisco (UCSF) Controller's Office. UCSF, as a State-controlled institution of higher learning, will be supporting the preclinical development efforts. The National Cancer Institute's Preclinical Prevent Cancer Program focuses on evaluating the efficacy and identifying intermediate biomarkers for potential chemopreventive agents in the preclinical setting prior to clinical trials.
Quick answers
Who was awarded contract 75N91018F00010?
75N91018F00010 was awarded to University Of Alabama At Birmingham by National Cancer Institute (National Institutes of Health) on September 17, 2018.
How much is contract 75N91018F00010 worth?
The government has obligated $1,271,041 on 75N91018F00010.
Is contract 75N91018F00010 an order under another contract?
Yes. 75N91018F00010 is a delivery order under HHSN261201500036I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract 75N91018F00010 competed?
The extent of competition for 75N91018F00010 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award